Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Neoplasms of the CNS

  Free Subscription


18.07.2022

2 AJNR Am J Neuroradiol
2 BMC Neurol
4 J Neurooncol
3 Neurology
1 Neuroradiology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJNR Am J Neuroradiol

  1. ALALI AA, Hanagandi PB, Maralani PJ
    Do We Need Gadolinium-Based Contrast Agents for Routine MRI Surveillance of Unoperated Pituitary Macroadenoma?
    AJNR Am J Neuroradiol. 2022;43:1024-1028.
    PubMed         Abstract available

  2. OSBORN AG, Louis DN, Poussaint TY, Linscott LL, et al
    The 2021 World Health Organization Classification of Tumors of the Central Nervous System: What Neuroradiologists Need to Know.
    AJNR Am J Neuroradiol. 2022;43:928-937.
    PubMed         Abstract available


    BMC Neurol

  3. NEWMAN NJ, Schniederjan M, Mendoza PR, Calkins DJ, et al
    Absence of lenadogene nolparvovec DNA in a brain tumor biopsy from a patient in the REVERSE clinical study, a case report.
    BMC Neurol. 2022;22:257.
    PubMed         Abstract available

  4. KONRATH E, Marhold F, Kindler W, Scheichel F, et al
    Perioperative levetiracetam for seizure prophylaxis in seizure-naive brain tumor patients with focus on neurocognitive functioning.
    BMC Neurol. 2022;22:250.
    PubMed         Abstract available


    J Neurooncol

  5. RECKER MJ, Kuo CC, Prasad D, Attwood K, et al
    Incidence trends and survival analysis of atypical meningiomas: a population-based study from 2004 to 2018.
    J Neurooncol. 2022 Jul 11. pii: 10.1007/s11060-022-04085.
    PubMed         Abstract available

  6. FUJITA Y, Nunez-Rubiano L, Dono A, Bellman A, et al
    IDH1 p.R132H ctDNA and D-2-hydroxyglutarate as CSF biomarkers in patients with IDH-mutant gliomas.
    J Neurooncol. 2022 Jul 11. pii: 10.1007/s11060-022-04060.
    PubMed         Abstract available

  7. KAWASHIMA M, Akabane A, Noda R, Segawa M, et al
    Interfractional change of tumor volume during fractionated stereotactic radiotherapy using gamma knife for brain metastases.
    J Neurooncol. 2022 Jul 9. pii: 10.1007/s11060-022-04075.
    PubMed         Abstract available

  8. MASSIMINO M, Vennarini S, Barretta F, Colombo F, et al
    How ten-years of reirradiation for paediatric high-grade glioma may shed light on first line treatment.
    J Neurooncol. 2022 Jul 9. pii: 10.1007/s11060-022-04079.
    PubMed         Abstract available


    Neurology

  9. MAZZUCCHI E, Pauletto G, Sabatino G, Ius T, et al
    Reader Response: Effect of Levetiracetam Use Duration on Overall Survival of Isocitrate Dehydrogenase Wild-Type Glioblastoma in Adults: An Observational Study.
    Neurology. 2022;99:84-85.
    PubMed        

  10. PALLUD J, Huberfeld G
    Author Response: Effect of Levetiracetam Use Duration on Overall Survival of Isocitrate Dehydrogenase Wild-Type Glioblastoma in Adults: An Observational Study.
    Neurology. 2022;99:85.
    PubMed        

  11. GANESH A, Galetta S
    Editors' Note: Effect of Levetiracetam Use Duration on Overall Survival of Isocitrate Dehydrogenase Wild-Type Glioblastoma in Adults: An Observational Study.
    Neurology. 2022;99:84.
    PubMed        


    Neuroradiology

  12. SHIN I, Park YW, Ahn SS, Kim J, et al
    Clinical factors and conventional MRI may independently predict progression-free survival and overall survival in adult pilocytic astrocytomas.
    Neuroradiology. 2022 Feb 3. pii: 10.1007/s00234-021-02872.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: